Microbot Medical issues stock and options in two unregistered transactions

Microbot Medical Inc.

Holder exercised 600,000 series H PIOs at $2.10/share, receiving 600,000 shares and new series J PIOs.
Remaining 1,324,488 series H PIOs expected to be exercised in additional closings by October 15, 2025.
Issued 30,000 Wainwright PIOs to H.C. Wainwright as placement agent compensation.
On September 23, issued 374,167 shares upon PA Options exercise, generating ~$896,000 gross proceeds.
All issuances rely on Section 4(a)(2) exemption; securities not registered under Securities Act.

item 1.01 item 3.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-25-016866
form_type: 8-K
ticker: MBOT
cik: 0000883975
company_name: Microbot Medical Inc.
filed_at: 2025-10-03T23:59:59+00:00
discovered_at: 2026-05-14T18:02:42.469217+00:00
generated_at: 2026-05-17T04:52:45.858921+00:00
sec_items: ["1.01", "3.02", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-25-016866
json_url: https://secwatch.observer/filing/0001493152-25-016866.json
markdown_url: https://secwatch.observer/filing/0001493152-25-016866.md
text_url: https://secwatch.observer/filing/0001493152-25-016866.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/883975/000149315225016866/0001493152-25-016866-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/883975/000149315225016866/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-25-016866

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.